Electrocautery method and apparatus

Information

  • Patent Grant
  • 8728072
  • Patent Number
    8,728,072
  • Date Filed
    Tuesday, February 6, 2007
    17 years ago
  • Date Issued
    Tuesday, May 20, 2014
    10 years ago
Abstract
An electrode structure and a mechanism for automated or user-selected operation or compensation of the electrodes, for example to determine tissue coverage and/or prevent arcing between bottom electrodes during electrocautery is disclosed.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The invention relates to tissue cauterization. More particularly, the invention concerns an electrocautery system with various electrodes and a mechanism for automated or user-selected operation or compensation of the electrodes.


2. Description of the Related Art


Various physiological conditions call for tissue and organ removal. A major concern in all tissue removal procedures is hemostasis, that is, cessation of bleeding. All blood vessels supplying an organ or a tissue segment to be removed have to be sealed, either by suturing or cauterization, to inhibit bleeding when the tissue is removed. For example, when the uterus is removed in a hysterectomy, bleeding must be inhibited in the cervical neck, which must be resected along the certain vessels that supply blood to the uterus. Similarly, blood vessels within the liver must be individually sealed when a portion of the liver is resected in connection with removal of a tumor or for other purposes. Achieving hemostasis is necessary in open surgical procedures as well as minimally invasive surgical procedures. In minimally invasive surgical procedures, sealing of blood vessels can be especially time consuming and problematic because there is limited access via a cannula and other small passages.


Achieving hemostasis is particularly important in limited access procedures, where the organ or other tissue must be morcellated prior to removal. Most organs are too large to be removed intact through a cannula or other limited access passage, thus requiring that the tissue be morcellated, e.g. cut, ground, or otherwise broken into smaller pieces, prior to removal.


In addition to the foregoing examples, there exist a variety of other electrosurgical instruments to seal and divide living tissue sheets, such as arteries, veins, lymphatics, nerves, adipose, ligaments, and other soft tissue structures. A number of known systems apply radio frequency (RF) energy to necrose bodily tissue. Indeed, some of these provide significant advances and enjoy widespread use today. Nevertheless, the inventors have sought to identify and correct shortcomings of previous approaches, and to research possible improvements, even when the known approaches are adequate.


In this respect, one problem recognized by the inventors concerns the small size of today's electrode structures. In particular, many electrosurgical instrument manufacturers limit the total length and surface area of electrodes to improve the likelihood of completely covering the electrodes with tissue. This small electrodes strategy results in the surgeon having to seal and divide multiple times to seal and divide long tissue sheets adequately. Such time consuming processes are also detrimental to patients, increasing anesthetic time and potentially increasing the risk of injury to surrounding structures, as the delivery of energy and division of tissue is repeated again and again.


The consequences of partial electrode coverage can be significant. This condition can cause electrical arcing, tissue charring, and inadequate tissue sealing.


Mechanical, e.g. blade, or electrosurgical division of tissue is performed immediately following tissue sealing, and the division of inadequately sealed tissue can pose a risk to the patient because unsealed vessels may hemorrhage. Arcing presents its own set of problems. If electrocautery electrodes generate an arc between them, instead of passing RF energy through targeted tissue, the tissue fails to undergo the intended electrocautery. Furthermore, depending upon the path of the arc, this might damage non-targeted tissue. Another problem is that adjacent electrodes in a multiple electrode system may generate electrical cross-talk or generate excessive thermal effect in the transition zone between two adjacent electrodes that fire sequentially. Previous designs prevented this by imposing a mechanical standoff for the jaws that the electrodes were fastened onto. However, this standoff prevented very thin tissue from making contact with the opposing electrodes, preventing an optimal electrical seal in these regions. These standoffs, if too shallow, can also result in arcing between electrodes.


At typical radiofrequency energy (RF) frequencies in the 300 kHz to 10 MHz range, tissue impedance is largely resistive. Prior to tissue desiccation, initial impedances can vary greatly depending on the tissue type and location, vascularity, etc. Thus, to ascertain the adequacy of tissue electrode coverage based solely on local impedance is imprecise and impractical. A feasible and dependable methodology for determining electrode coverage by tissue would allow for the development of electrodes of greater length and surface area for use in the safe and rapid sealing and division of tissue sheets during surgical procedures. It would therefore be advantageous to provide a methodology for determining the area of tissue coverage of one or more electrodes.


SUMMARY

An electrode structure and a mechanism for automated or user-selected operation or compensation of the electrodes, for example to determine tissue coverage and/or prevent arcing between bottom electrodes during electrocautery is disclosed.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a block diagram of the components and interconnections of an electrocautery system according to the invention;



FIG. 2 is a combination block and schematic diagram illustrating an electrocautery device with a first embodiment of compensating circuitry according to the invention;



FIG. 3 is a combination block and schematic diagram illustrating an electrocautery device with a second embodiment of compensating circuitry according to this invention;



FIG. 4 is a combination block and schematic diagram illustrating an electrocautery device with a third embodiment of compensating circuitry according to the invention;



FIG. 5 is a combination block and schematic diagram illustrating an electrocautery device with circuitry for selectively firing electrodes according to the invention; and



FIG. 6 is a block diagram showing an electrode having a dielectric coating according to the invention.





DETAILED DESCRIPTION

In view of the problems of conventional technology that the inventors have recognized (as discussed above), the inventors have sought to improve the ability of a user to control electrocautery electrodes after said electrode have been inserted into the body. Further areas of their focus include improving the efficiency of transferring power to electrode structures, and improving the accuracy of measurements taken from the electrode structure in situ. One benefit of implementing these improvements is the ability to use larger electrode surfaces, with the advantageous consequences discussed above.



FIG. 1 illustrates one embodiment of electrocautery system 100. The system 100 includes an electrode structure 102 that is electrically driven by a power, electrode selector, and compensator module 108. The module 108 is operated in accordance with user input conveyed via one or more user interfaces 110.


As explained below in greater detail, certain components of the system 100 may be implemented with digital data processing features. These may be implemented in various forms.


Some examples include a general purpose processor, digital signal processor (DSP), application specific integrated circuit (ASIC), field programmable gate array (FPGA) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. A general purpose processor may be a microprocessor, but in the alternative, the processor may be any conventional processor, controller, microcontroller, or state machine. A processor may also be implemented as a combination of computing devices, e.g. a combination of a DSP and a microprocessor, a plurality of microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration.


As a more specific example, a digital data processing includes a processor, such as a microprocessor, personal computer, workstation, controller, microcontroller, state machine, or other processing machine, coupled to digital data storage. In the present example, the storage includes a fast-access storage, as well as nonvolatile storage. The fast-access storage may be used, for example, to store the programming instructions executed by the processor. Storage may be implemented by various devices. Many alternatives are possible. For instance, one of the components may be eliminated. Furthermore, the storage may be provided on-board the processor, or even provided externally to the apparatus.


The apparatus also includes an input/output, such as a connector, line, bus, cable, buffer, electromagnetic link, antenna, IR port, transducer, network, modem, or other means for the processor to exchange data with other hardware external to the apparatus.


As mentioned above, various instances of digital data storage may be used, for example, to provide storage used by the system 100 (FIG. 1), to embody the storage, etc. Depending upon its application, this digital data storage may be used for various functions, such as storing data, or to store machine-readable instructions. These instructions may themselves aid in carrying out various processing functions, or they may serve to install a software program upon a computer, where such software program is then executable to perform other functions related to this disclosure.


An exemplary storage medium is coupled to a processor so the processor can read information from, and write information to, the storage medium. In the alternative, the storage medium may be integral to the processor. In another example, the processor and the storage medium may reside in an ASIC or other integrated circuit.


In contrast to storage media that contain machine-executable instructions (as described above), a different embodiment uses logic circuitry to implement processing data processing features of the system.


Depending upon the particular requirements of the application in the areas of speed, expense, tooling costs, and the like, this logic may be implemented by constructing an application-specific integrated circuit (ASIC) having thousands of tiny integrated transistors. Such an ASIC may be implemented with CMOS, TTL, VLSI, or another suitable construction. Other alternatives include a digital signal processing chip (DSP), discrete circuitry (such as resistors, capacitors, diodes, inductors, and transistors), field programmable gate array (FPGA), programmable logic array (PLA), programmable logic device (PLD), and the like.


Electrode Structure 102


Referring to FIG. 1, the electrode structure 102 includes first and second electrode surfaces 103-104. The electrode surface 104 is formed by a group of electrodes, such as individual electrodes 104a, 104b, etc. In one instance, the electrodes may be substantially contiguous. The electrode surface 103, in one instance, includes a single electrode, as illustrated. In another instance, the surface 103 includes multiple electrodes, of the same or different number than the electrodes 104.


In one embodiment the electrode surfaces 103-104 are arranged to provide electrical power to a targeted tissue area using opposed, bipolar electrodes. The use of opposed, bipolar electrodes is advantageous because it concentrates energy flux between the electrodes and limits the effect on adjacent tissue that is not confined within the opposed electrodes.


In one case, the electrode structures 103-104, may have generally similar geometries to contact tissue in a symmetric fashion. Alternatively, the electrode structures 103-104 may have dissimilar geometries. For example, one electrode structure may comprise a probe for insertion into a natural body orifice with the other electrode structure being structured to engage an exterior tissue surface apart from the body orifice. In some instances, more than two electrode structures may be employed, but at least two electrode structures, or separate regions of a single structure, are energized with opposite polarity to apply RF energy to the targeted tissue. In some instances, the electrode structures may be different regions formed as part of a single support structure, e.g. a single elastic tube or shell which may be placed over an organ or other tissue mass and which has two or more electrode surfaces formed thereon.


The different electrode surfaces are isolated from each other when high frequency energy of the same or opposite polarity is applied to them. In still other instances, a single electrode structure may have a plurality of electrically conductive or active regions, where the electrically conductive regions may be energized with the same or an opposite polarity.


In some instances, it may be desirable to provide additional structure or components on the electrode structures to enhance or increase the effective electrical contact area between the electrode structure and the tissue. In particular, the electrode structures may include tissue-penetrating elements to enhance electrical contact i.e. reduce electrical impedance between the electrode and the tissue and increase the total surface contact area between the electrode and the tissue. Exemplary tissue-penetrating elements include needles, pins, protrusions, channels, or the like. A particular example includes pins having sharpened distal tips so that they can penetrate through the tissue surface and into the underlying tissue mass. The pins may have depths in the range from 1 mm to 5 cm, or from 3 mm to 1 cm. The diameters of the pins range from 0.1 mm to 5 mm, or from 0.5 mm to 3 mm. In one instance, the pins are evenly distributed over the tissue-contact area of an electrode structure, with a pin density in the range from 0.1 pin/cm2 to 10 pin/cm2, or from 0.5 pin/cm2 to 5 pin/cm2. When tissue-penetrating elements are used, they may be dispersed in a general uniform matter over the electrically active area of the electrode structure. The pins or other tissue-penetrating elements may be provided in addition to an electrically conductive conformable or rigid electrode surface, but in some instances the pins may provide the total electrically conductive or active area of an electrode structure.


In one example, the electrodes comprise a plurality of different electrically conductive regions, where the regions may be electrically isolated from each other or may be electrically coupled to each other. Single electrode structures may include three, four, five, and as many as ten or more discrete electrically conductive regions thereon. Such electrically conductive regions may be defined by electrically insulating regions or structure between them.


One example of a multiple-electrode surface 104 is a plurality of electrically conductive strips that are separated by a gap which may be an air gap, a plastic member or other insulator. The gap is preferably less than 0.5 mm. In addition, multiple tissue-penetrating pins may be disposed along the length of each electrically conductive strips. The electrically conductive strips may be energized in an alternating polarity configuration. Most simply, opposing strips are connected to opposite polls on a single power supply. Electrical connections may be rearranged, however, to power the strips in virtually any pattern. Moreover, it is also possible to isolate different regions of each strip electrically to permit powering those regions at different polarities; or to set the electrodes to the same polarity but with various sequences of firing pattern that can include firing every electrode, firing specific electrode, or firing multiple electrodes simultaneously.


Although shown as flat plates, the electrode structure 102 may be implemented in a variety of different shapes without departing from the scope of the invention. For instance, the electrode structures 103-104 may be generally curved to facilitate placement over a tubular body structure or tissue mass. In one case, electrode configurations are specifically configured to have a geometry intended to engage a particular organ or tissue geometry. In other cases, the electrode configurations are conformable so that they can be engaged against and conform to widely differing tissue surfaces. In this regard, electrode strips may be constructed from such material as, for example, conformable meshes, permitting the electrode structures to be flattened out or to assume a wide variety of other configurations. Additionally, the insulating structures may also be formed from a flexible or conformable material, permitting further reconfiguration of the electrode structures. The structure 102 may be implemented according in any one, or a combination, of known shapes configurations, which are familiar to the ordinarily skilled artisan. Some exemplary shapes include opposing jaws, cylinder, probe, flat pads, etc. In this regard, the electrodes may be configured in any manner suitable for engaging a tissue surface.


Thus, the electrodes can be rigid, flexible, elastic, inelastic (non-distensible), planar, non-planar, or the like, and may optionally employ tissue-penetrating elements to enhance electrical contact between the electrode structure and the tissue, as well as to increase the electrode area. Electrode configurations may be conformable so that they can be engaged against and conform to widely differing tissue surfaces, or they are specifically configured to have a geometry intended to engage a particular organ or tissue geometry. In both instances, the electrode structures may further be provided with tissue-penetrating elements.


Optionally, electrode structures may include both a conductive surface and a non-conductive surface. In some embodiments this is accomplished by leaving one surface as an exposed metallic face, while the other surface of the electrode is covered or insulated with, for example, a dielectric material. In the case of rigid electrodes, the insulation can be laminated, coated, or otherwise applied directly to the opposed surface. In the case of flexible and elastic electrodes, the insulating layer is flexible so that it can be expanded and contracted together with the electrode without loss or removal. In some cases, a separate, expandable sheet of material covers the face for which insulation is desired. In some embodiments, all electrode surfaces may be coated with a dielectric material.


In one embodiment, the electrically active regions of the electrode structures have an area ranging from one to fifty cm2 or larger. Further details and examples of electrode structures are explained in the U.S. patent applications as identified incorporated herein by reference above.


Power Supply 106


The power supply 106 includes one or multiple power supplies. Basically, the power supply 106 generates high frequency, such as RF, power for application to targeted tissue through one or more electrically active regions of the electrode structure 102. As described below, the duration and magnitude of power cauterizes or necroses tissue between the electrode surfaces 103-104.


Exemplary frequency bands include 100 kHz to 10 MHz or 200 kHz to 750 kHz. Power levels depend on the surface area and volume of tissue being treated, with some examples including a range from 10 W to 500 W, or 25 W to 250 W, or 50 W to 200 W. Power may be applied at a level of from 1 W/cm2 to 500 W/cm2, or 10 W/cm2 to 100 W/cm2, for example.


The power supply 106 may be implemented using various conventional general purpose electrosurgical power supplies. The power supply 106 may employ sinusoidal or non-sinusoidal wave forms and may operate with fixed or controlled power levels. Suitable power supplies are available from commercial suppliers.


In one embodiment, the power supply provides a constant output power, with variable voltage and current, where power output varies based upon load. Thus, if the system sees a very high impedance load, the voltage is maintained at a reasonable level to avoid arcing. With tissue electrocautery, impedance ranges from two ohms to 1000 ohms, for example. By applying constant power, the power supply 106 can provide significant current at low impedance to achieve initial desiccation when the tissue is first being cauterized and, as cauterization proceeds, to apply higher voltage to complete the tissue sealing process. Thus, the power supply 106 can provide larger current and smaller voltage at the beginning of the cauterization process and a higher voltage and lower current at the sealing phase of the process. Control of such power generator is based, at least in part, on the system 100 monitoring power.


In one embodiment, the power supply 106 includes a mechanism for setting the desired power. This setting may occur by real-time control, pre-set selection by a user, default settings, selection of predetermined profile, etc. In one embodiment, pulse width modulation is used in connection with a flyback transformer. The system charges a primary of the flyback transformer and produces a regulated output. The secondary may be regulated, for example, to 15 volts at a desired number of amperes to produce the desired power output. Based upon the period, as determined by the width of the pulse which charges the primary, the power curve is determined. Thus, the invention establishes a certain level of power in the primary of the flyback transformer and the same level of power is provided by the secondary without regard to impedance of the load, i.e. the tissue.


The power supply 106 may include digital data processing equipment, such as mentioned above. This optional equipment, if implemented, is used to establish and control features and operation of the power supply 106.


As illustrated, the power supply 106 is a source of power for multiple electrodes of the structure 102. Accordingly, the power supply 106, or the module 108, provides multiple output channels, each of which is independently adjustable. In this embodiment, the system 100 includes a conductive supply path of multiple conductors 108c to provide power to the electrodes, and a return path 108b for providing a ground path and/or feedback to the power supply or vice versa, depending on the direction of current flow.


In a more particular embodiment, the module 108 has multiple outputs 108c routed to the individual electrodes by a digital data processor of the module 108. These multiple outputs are independently operated by the processor and readily modulated and assignable. Thus, the processor may assign an output to any one or more of the electrode elements at a certain point in operation of a cauterization cycle, and dynamically reassign them other points of time. For example, if the power source were a four channel power source and the electro-surgical device had sixteen electrodes, then each channel may support four electrodes in electro-surgical device. However, this arrangement may be varied so that some channels support more electrodes than others.


User Interface 110


The user interface 110 comprises one or more devices for a human to exchange information with the module 108, including the power supply 106. There may be a common user interface, or separate user interfaces for each component 106, 108. The user interface may be implemented in various ways, with the following serving as some examples. As for human-to-machine flow, some examples of the interface 110 include buttons, dials, switches, keyboards, remote control console, or other mechanical devices. Other examples include pointing devices such as a mouse, trackball, etc. Still other examples include digitizing pads, touch screens, voice input, or any other example suitable for the purposes described herein. As for the machine-to-human exchange, the interface 110 may employ a video monitor, display screen, LEDs, mechanical indicators, audio system, or other example suitable for the purposes described herein.


User input is conveyed from the interface to the module 108 via the link 108a.


Sensors


The system 100 may also include various sensors attached to various components of the system 100. The sensors, which are not shown in FIG. 1 to avoid cluttering the diagram, may be attached to components such as the electrodes 103-104, subparts of the module 108, equipment of the power supply 106, and the like. Examples of these sensors include devices for sensing voltage, current, impedance, phase angle between applied voltage and current, temperature, energy, frequency, etc. More particular, some of these devices include voltmeters, analog-to-digital converters, thermistors, transducers, ammeters, etc.


Module 108


As shown above, the module 108 includes one or more power supplies 106. Aside from this function, module 108 may be implemented to perform some or all of automated or user-selected operation or compensation of the electrodes in the manner shown below. According to one aspect, the module 108 may be used to target a specific region of tissue, or the control firing order of electrodes, by selectively limiting power application to electrodes whose selection is predetermined, machine-selected, or user-selected. According to another aspect, the module 108 may introduce impedance into the electrode circuitry to provide a predetermined, machine-selected, or user-selected impedance matching or compensation.


According to one optional aspect of the module 108, the module 108 may target a specific region of tissue by selectively limiting power application to electrodes whose selection is predetermined, machine-selected, or user-selected. In this regard, the module 108 has a variety of outputs 108b-108c individually coupled to each of the electrodes 103-104. As one example, the outputs 108b-108c may comprise wires, cables, busses, or other electrical conductors. In the illustrated example, there are multiple conductors 108c leading to the multiple electrodes 104a, 104b, etc.


The module 108 applies voltage from the power supply 106 across the first and second electrode surfaces 103-104, such that the voltage is applied exclusively to selected ones of the electrodes. These electrodes may be selected according to user input from the interface 110, selected by a machine-implemented analysis, and/or selected by a default state. In this regard, the module 108 may include a switching network of electrical and/or mechanical switches, relays, or other mechanism to provide power to selected ones of the electrodes. As shown, the power supply 106 is integrated into the module 108, and computer control selectively activates selected output conductors.


Whether by independent switching network or computer regulated activation of output conductors, the module 108 activates electrodes according to input from user interface 110, or input from a machine such as a digital data processing device as discussed above. Depending upon the nature of the application, such controlled application of power to electrodes may be performed in accordance with a machine-selected criteria or analysis, default state, or user input.



FIG. 5 illustrates a typical application of one example of a processor-controlled switching network, shown in context of two power supplies, electrode structures, and a targeted tissue region. In this example, the electrode surfaces are configured as follows. The electrode surfaces are substantially parallel during performance of electrocautery, each electrode of one surface is aligned with its counterpart in the other electrode surface. In this example, there are two electrodes from the upper surface corresponding to each electrode of the lower surface.


Significantly, the module 108 selectively limits power application to certain electrodes, to target a specific region of tissue. Electrodes may be selected for a different end, as well. Namely, the module 108 may monitor or control the selection of electrodes to prevent firing of adjacent electrodes of the same electrode surface concurrently or sequentially. Ensuring that electrode firing occurs in this spaced-apart fashion prevents unintentional arcing between electrodes and improves the effectiveness of electrocautery. In one embodiment, the controlled firing order is implemented by computer control, and particularly, by a digital data processing component of the module 108. As an alternative to computer control, mechanical means may be used, such as an electromechanical distributor or other device.


In another embodiment, the module 108 may introduce impedance into the electrode circuitry to provide predetermined, machine-selected, fixed, or user-selected impedance matching or compensation. In other words, the module 108 contains a mechanism to electrically introduce impedance into a circuit containing the power supply, the outputs 108b-108c, and the electrodes 103-104.


More particularly, the module 108 includes capacitors, inductors, and/or other impedance elements that can be adjusted or selectively introduced to control the amount of impedance in the circuit containing the power supply and electrodes 103-104. These impedance elements may comprise discrete elements, integrated circuit features, or other constructs suitable for the purposes described herein. The module 108 establishes this impedance matching or compensation according to directions from a user, machine-implemented analysis, and/or default setting.


One example of an adjustable impedance is an adjustable inductor that may comprise any known inductance, such as a coil of conducting material wrapped around an adjustable ferromagnetic core or discrete inductors. In this example, the overall inductance is selectively increased by closing a switch that may be activated manually, mechanically, electrically, or by any means suitable to the purposes of this disclosure, for example, via the user interface 110.



FIG. 2 illustrates an electrode arrangement having an inductance in series with each electrode of an upper electrode surface (as illustrated). FIG. 3 shows a different example, including an inductance in series with each electrode of the lower electrode surface (as illustrated). In a different example still, FIG. 4 contains “T” type network where a capacitor is placed in series with each electrode of the upper electrode surface. Additionally, a different inductor is placed in parallel with each pair of electrodes that are designed to be activated together. The examples of FIGS. 2-4 may employ impedance elements that are fixed, adjustable, or a combination of fixed and adjustable. Furthermore, in connection with the electrodes having a dielectric coating on their surface, a nearly limitless number of additional circuitry configurations for impedance matching and/or compensation will be apparent to ordinarily skilled artisans having the benefit of this disclosure.


In addition to the arrangement for introducing impedance into the electrode circuits, another consideration is the value of such impedance elements. In one example, the impedance is selected to achieve maximum power transfer and to make accurate power measurements. In this regard, the impedance is chosen to maintain an impedance match between the RF generator, namely, the power supply 106, and the tissue. Impedance matching is achieved when the phase-angle between applied voltage and current is zero. Namely, additional inductance is increased to compensate for the increased capacitive reactance. In one example, this is carried out with a continuously variable inductor, with a finite range and nearly infinite resolution. Such an inductor can be adjusted to a near zero phase. In a different example, impedance matching is carried out by using discrete inductive elements in an appropriate arrangement, such as shown in FIGS. 2-4, to find the least possible phase angle, though this may not be exactly zero.


Having described the structural features of the invention, the operational aspects of the invention will be described. The steps of any method, process, or algorithm described in connection with the embodiments disclosed herein may be embodied directly in hardware, in a software module executed by hardware, human-performed steps, or a combination of these.


A sequence for performing an electrocautery procedure uses an electrocautery system that includes an electrode structure and a mechanism for automated or user-selected operation or compensation of the electrodes. For ease of explanation, but without any intended limitation, this example is described in the specific context of the system 100 of FIG. 1.


In a first step, different parameters for operating the system 100 are selected. In one example, one or more human users select these parameters and convey them to the system 100 via the user interface 110. In a different example, the parameters for operating the system 100 are selected by digital data processing equipment aboard the module 108. In this case, the parameters are set according to user input, default values, measurements gathered by the various sensors installed in the system 102, programming of the module 108, etc.


Without any intended limitation, the following are some non-exclusive examples of parameters that may be selected in the first step:

    • (1) Identity of individual electrodes to be activated e.g., FIG. 5 in order to focus energy of the electrodes 103-104 on a specific region of tissue.
    • (2) Firing order of electrodes.
    • (3) Assessment or measurement of magnitude of impedance, e.g. FIGS. 2-4, to be used in compensating and/or impedance matching between the power supply 106 and electrodes 103-104.
    • (4) Parameters of electrical power to be applied in electrocautery, such as magnitude, frequency, phase, or other characteristics of voltage, current, power, etc.
    • (5) Any other parameter by which the operation of the system 100 can be varied.


In a next step appropriately trained personnel apply the electrodes 103-104 to a targeted tissue region to be electrocauterized. The manner of applying the electrodes 103-104, varies according to the construction of the electrodes 103-104, the nature of the targeted body part, the procedure to be performed, and other such factors. There may be circumstances where both electrode structures 103-104 are used within the body, and other embodiments where one electrode is inserted into the body and the other electrode used externally, i.e. bipolar or monopolar applications, as is know in the art.


In a specific example of this next step, there are multiple electrodes of one surface, such as 104, corresponding to one electrode of the other surface, such as 103. Optionally, personnel arrange the first and second electrode surfaces 103-104 so that the electrode surfaces are substantially parallel, and each one of the second electrodes is aligned with its corresponding first electrodes, although alignment is preferably obtained during manufacture of the device. FIGS. 2-5 show examples of the final arrangement.


In a further step, directions are given to begin electrocautery. This occurs by user input submitted via the interface 110. For example, a user may press a start button, utter a start command, press a foot pedal, trip a lever, or perform other action. In a different example, electronically occurs upon expiration of a user-initiated timer.


In a still further step, the system 100 responds to the start command and electrocautery is conducted. Here, the system 100 directs bipolar RF power at target tissue regions defined by spaced-apart placement of the electrode structures 103-104. The use of opposed, bipolar electrodes concentrates energy between the electrodes and limits the effect on adjacent tissue that is not confined within the opposed electrodes. In practice, power may be applied for a time sufficient to raise the tissue temperature in the tissue mass being treated to above a threshold level required for cauterization or necrosis, such as 60-80° C., or even higher.


More specifically, electrocautery is conducted according to the configuration set. For instance, the power supply 106 operates according to the power settings established. Moreover, the module 108 acts to invoke individual ones of the electrodes according to the electrode combination selected. In other words, the module 108 applies voltage from the power supply 106 across the first and second electrode surfaces 103-104, such that voltage is applied exclusively to the electrodes selected in. In the case of computer control, this is achieved by the module 108 selectively applying power to the selected electrodes.


As a further enhancement to the use of selected electrodes, the electrodes may be activated using a selected firing order. In this example, the module 108 applies voltage from the power supply 106 across the first and second electrode surfaces 103-104, such that voltage is applied to one or more of the first electrodes 102 and one or more of the second electrodes 103 at any one time, and the module 108 prevents firing of adjacent electrodes of the same electrode surface concurrently or sequentially. The module 108 may further implement a predetermined or user-selected firing order.


For example, one way of preventing interaction, either thermal or electrical, between two or more multiple electrodes in an RF device with multiple electrodes is to alter the firing sequence of electrodes so that adjacent electrodes are never sequentially charged. For example, instead of sequential firing a four electrode system, where the electrodes are sequentially numbered 1, 2, 3, 4, the invention fires them in an order such as 3,1,4,2, 4,2, 4,1,3,1,3, etc. so that adjacent electrodes are not fired sequentially. Firing times may be different for each electrode to balance the energy delivered in such a sequence where some electrodes fire more frequently than others. This prevents cross-talk during the transmission from one electrode to another as well as cumulative effects of sequential heat build-up in the transition area between the two electrodes. Additionally, rounded electrodes can minimize the edge effect that occurs between electrodes and at any transition surface.


Additionally, if one electrode surface or both opposing surface of conductive, typically metal, electrodes are coated with dielectric, non-conductive materials, RF energy may still be transmitted through tissue between them via capacitive coupling. FIG. 6 is a block diagram showing an electrode having a dielectric coating according to the invention. However, due to the non-conductive nature of the surface coating the electrode surfaces does not create a short circuit if brought into close proximity or contact. In this way, if a portion of an electrode pair only partially captures tissue, i.e. there is a small, 5 mm air gap between a portion of the electrodes, the RF energy still passes through the tissue, as opposed to going around the tissue and flowing directly between the close proximity electrodes. This is especially important late in the sealing cycle as the tissue impedance rises. When the tissue impedance is high the energy seeks alternate pathways of lower resistance, such as between exposed electrode sections. These dielectric layers can be thin coats of polymers, such as Teflon, metal oxides, such as titanium, tungsten, or tantalum or ceramics. To obtain adequate capacitance these layers may be in the micron range of thickness.


In an alternative embodiment, a variety of different tissue cauterization patterns can be achieved with the system 100 by selectively energizing different ones of the electrode surfaces or regions. By selectively energizing two adjacent electrodes, while leaving all other electrodes non-energized, a limited tissue region is cauterized. In contrast, by energizing other multiple electrode surfaces, a larger region is cauterized. Slightly different patterns are achieved depending on the precise pattern of electrode surface polarity. In other embodiments, the electrode surfaces can be energized in an alternating pattern of polarity to produce a tissue cauterization pattern. Different patterns may also be used to produce somewhat different patterns of cauterized tissue.


A different approach for selected firing is employed to prevent local areas of high impedance from impacting the overall system impedance along the entire electrode, and thus potentially reducing the power output of the entire system as voltage reaches its maximal capacity. Here, electrodes are activated to prevent one area that has already been well sealed and has thus reached high impedance value from affecting other regions in which the tissue is not yet sealed, and is thus at a lower impedance. Optionally, the module 108 may employ unique power and energy delivery profiles for each electrode or electrode pair, based on the properties of the tissue in a specific electrode location/position.


The performance of electrocautery employs the selected impedance compensation and/or matching selected. As a result, power delivered from the power supply 106 is delivered to the targeted tissue region with less electrical loss.


The system 100 may further sense and automatically adjust conjugate matching impedance. In response, the module 108 adjusts the impedance applied to the conductive path containing the electrode surfaces 103-104 and power supply 106.


Alternatively, the sensors may provide raw data to the module 108, which analyzes whether and how to adjust impedance. In a different instance, the module 108 may adjust impedance responsive to direction or data from the sensors. This can be carried out by changing the frequency of RF energy delivered by the power supply 106. For example, in one embodiment the module 108 senses whether or not tissue is present at each electrode at the beginning of a cauterization cycle by measuring any of impedance, pressure, or any combination of these and/or other parameters. If tissue is not present at any electrode, then such electrode pair is idle; the module 108 deactivates firing of this electrode, and/or provides a warning to an operator via the user interface 110. The module 108 may also provide a status indicator for each electrode pair that indicates whether the sealing cycle is active or completed with regard to each electrode pair. In this embodiment, each electrode pair may include a mode status indicator, such as an LED for example, that indicates any of an idle, active, or complete condition, once a cauterization cycle is commenced.


The invention also addresses the problem of determining the area of tissue coverage of one or more electrodes through the use of dielectric coated electrode surfaces (See FIG. 6). With a suitable RF generator and with electrode surfaces coated with a dielectric coating, determination of tissue coverage may be obtained by measuring phase-angle of RF voltage and current. Because a dielectric coating essentially forms a capacitive coupling to tissue, for a given dielectric material thickness, the capacitance is a function of the area of coverage.


The basic formula for a capacitor is:

C=∈0rA/d


Expressed in Farads, where ∈0 is the permittivity of free-space (8.854E-12), ∈r, is the relative permittivity of the dielectric, A/d is the ratio of the area and the dielectric thickness.


At a given frequency, the reactance is expressed as

Xc=1/ωC

where ω is 2*Pi*Frequency.


A suitable RF generator is required to insert a conjugate impedance inductance in this case to cancel out the capacitive reactance with a fully covered electrode and to measure the phase-angle of RF voltage and current. When an electrode is only partially covered, the capacitance changes i.e. becomes smaller, because the effective area is smaller. As a result, the reactance and, ultimately, the phase-angle of RF voltage and current change. While the magnitude of change is affected in part by the tissue resistance, it is believed that this methodology allows the greatest degree of determination of electrode coverage by tissue.


A further advantage of such a methodology may signal the RF generator's control algorithm to change frequency, e.g. increase, with smaller surface areas, thus maintaining maximum power transfer while minimizing chances for electrical arcing and tissue charring. Potential electrical arcing and tissue charring conditions may be detected rapidly by rapid changes in phase and/or impedance and by appreciating that electrodes which are only partially covered by tissue may be used to signal the RF generator control algorithm to shorten or change treatment parameters.


To achieve maximum power transfer and to make accurate power measurements, it is desirable to maintain an impedance match between the RF generator and the tissue. Impedance matching is achieved when the phase-angle is zero. Several methodologies may be used to attain near-zero phase. One such methodology uses additional reactive elements e.g. greater inductance, to compensate for the increased capacitive reactance. This approach can be achieved in two different ways:

  • (1) Via the insertion of a continuously variable inductor with a finite range and nearly infinite resolution, such an inductor can be adjusted to a near zero phase; or
  • (2) Via the insertion of discrete elements, e.g. inductors to find the lowest phase, though this may not be near-zero phase.


In both cases, electromechanical devices are required within the RF generator.


Another methodology of achieving maximum power-transfer, e.g. zero phase, is by changing the RF frequency. Given that the reactance is frequency dependent, this methodology allows the RF generator to compensate for phase discrepancy by electronically changing frequency. This may not require any mechanical devices such as relays, servos, etc. Further, the RF generator can change frequency during operation rather than first interrupting RF power to change elements. Thus, this may be the most desirable methodology.


Although the invention is described herein with reference to the preferred embodiment, one skilled in the art will readily appreciate that other applications may be substituted for those set forth herein without departing from the spirit and scope of the present invention. Accordingly, the invention should only be limited by the Claims included below.

Claims
  • 1. A bipolar electrocautery apparatus, comprising: a plurality of adjacent first electrodes forming a first electrode array;one or more second electrodes, the first electrode array and the one or more second electrodes forming a plurality of opposed bipolar electrode pairs, at least one of the electrodes in at least one of the plurality of electrode pairs coated with a dielectric material;a power supply,configured to apply a voltage across each of the plurality of electrode pairs anda determinator configured to determine an amount of tissue coverage between the at least one of the plurality of electrode pairs based on a capacitance of the dielectric material of the at least one of the plurality of electrode pairs.
  • 2. The apparatus of claim 1, at least one of said first electrodes and said second electrode having rounded edges to minimize an edge effect that occurs both between electrodes and at any transition surface.
  • 3. The apparatus of claim 1, wherein the dielectric material allows RF energy to be transmitted between said electrodes via capacitive coupling.
  • 4. The apparatus of claim 3, at least of portion of said first electrodes and said at least one second electrode having a spaced relation defining an insulating gap of less than 0.5 mm.
  • 5. The apparatus of claim 3, said electrode surface coating comprising a polymer.
  • 6. The apparatus of claim 5, said polymer comprising any of: Teflon, metal oxides of any of titanium, tungsten, and tantalum, or a ceramic material.
  • 7. The apparatus of claim 3, said surface coating comprising: at least one coating layer.
  • 8. The apparatus of claim 3, wherein the dielectric coating forms a capacitive coupling to tissue during the cauterization cycle; and wherein for a given dielectric coating thickness, capacitance is a function of the area of coverage.
  • 9. The apparatus of claim 1, wherein the power supply is further configured to activate said electrodes in a selected firing order that prevents firing of adjacent electrodes concurrently or sequentially.
  • 10. The apparatus of claim 1, said power supply comprising: an RF generator configured to be selectively operable so as to be able to selectively apply a voltage from the power supply to insert a conjugate impedance in the form of an inductance to cancel out capacitive reactance with a fully covered electrode and to permit measurement of phase-angle of RF voltage and current;wherein when an electrode is only partially covered with tissue, its capacitance changes; andwherein, as a result, reactance and phase-angle of RF voltage and current change.
  • 11. The apparatus of claim 10, wherein the RF generator is configured with a generator control algorithm for changing RF generator frequency upon detection of smaller electrode surface areas to maintain maximum power transfer while minimizing excessive energy delivery.
  • 12. The apparatus of claim 11, wherein the power supply is further configured to detect rapid changes in impedance.
  • 13. The apparatus of claim 12, wherein the generator control algorithm is adapted to respond to electrodes which are only partially covered by tissue to convey a signal to said RF generator control algorithm to shorten or change treatment parameters.
  • 14. The apparatus of claim 10, wherein the generator is further configured to maintain an impedance match between said RF generator and tissue, wherein impedance matching is achieved when a phase-angle is about zero.
  • 15. The apparatus of claim 14, wherein the generator is further configured to maintain an impedance match between said RF generator and tissue by way of utilizing one or more reactive elements that compensate for increased capacitive reactance.
  • 16. The apparatus of claim 15, wherein the RF generator is configured to maintain an impedance match between said RF generator and tissue further by way of an operational approach comprising any of: an insertion of a continuously variable inductor with a finite range and nearly infinite resolution, wherein said inductor adjustable to a near zero phase; an insertion of discrete elements to find a lowest phase; or,a change of frequency of said RF generator, wherein said RF generator compensates for phase discrepancy by electronically changing frequency.
  • 17. The apparatus of claim 1, wherein the determinator is configured to determine the amount of tissue coverage based on a difference between the capacitance of the dielectric material when there is full tissue coverage between the at least one of the plurality of electrode pairs and the capacitance of the dielectric material when there is partial tissue coverage between the at least one of the plurality of electrode pairs.
  • 18. A method of bipolar electrocautery, comprising the steps of: providing a plurality of adjacent first electrodes forming a first electrode array;providing one or more second electrodes;providing a plurality of opposed bipolar electrode pairs, each of the bipolar electrode pairs comprising one of the plurality of first electrodes and one of the one or more second electrodes, at least one of the electrodes in at least one of the plurality of electrode pairs coated with a dielectric material;selectively applying a voltage from a power supply across each of the plurality electrode pairs; anddetermining an amount of tissue coverage between the at least one of the plurality of electrode pairs based on a capacitance of the dielectric material of the at least one of the plurality of electrode pairs.
  • 19. The method of claim 18, wherein the dielectric material allows RF energy to be transmitted between said electrodes via capacitive coupling.
  • 20. The method of claim 18, further comprising the step of: activating said electrodes in a selected firing order that prevents firing of adjacent electrodes concurrently or sequentially.
  • 21. The method of claim 18, further comprising the step of: measuring a phase-angle of RF voltage and current; wherein said dielectric coating forms a capacitive coupling to tissue; andwherein for a given dielectric coating thickness, capacitance is a function of the area of coverage.
  • 22. The method of claim 21, further comprising the step of: providing an RF generator control algorithm for changing RF generator frequency upon detection of smaller electrode surface areas to maintain maximum power transfer while minimizing any of electrical arcing, suboptimal energy delivery, or excessive energy delivery.
  • 23. The method of claim 18, further comprising the step of: providing an RF generator selectively operable to insert a conjugate impedance in the form of an inductance to cancel out capacitive reactance with a fully covered electrode and to permit measurement of phase-angle of RF voltage and current;wherein when an electrode is only partially covered, capacitance changes; andwherein, as a result, reactance and phase-angle of RF voltage and current change.
  • 24. The method of claim 18, further comprising the step of: detecting any of electrical arcing, suboptimal energy delivery, or excessive energy delivery by determining rapid changes in impedance.
  • 25. The method of claim 18, further comprising the step of: using electrodes which are only partially covered by tissue to signal said RF generator control algorithm to shorten or change treatment parameters.
  • 26. The method of claim 18, further comprising the step of: maintaining an impedance match between said RF generator and tissue; wherein impedance matching is achieved when a phase-angle is about zero.
  • 27. The method of claim 18, further comprising the step of: providing one or more reactive elements which compensate for increased capacitive reactance.
  • 28. The method of claim 27, further comprising any of the steps of: inserting a continuously variable inductor with a finite range and nearly infinite resolution, wherein said inductor adjustable to a near zero phase; inserting discrete elements to find a lowest phase; andchanging the frequency of said RF generator, wherein said RF generator compensates for phase discrepancy by electronically changing frequency.
  • 29. A bipolar electrocautery apparatus, comprising: a plurality of adjacent first electrodes forming a first electrode array;one or more second electrodes;a plurality of opposed bipolar electrode pairs, each of the bipolar electrode pairs comprising one of the plurality of first electrodes and one of the one or more second electrodes; wherein each electrode of the electrode pairs comprises a surface coated with a dielectric or non-conductive material that allows RF energy to be transmitted between said electrodes via capacitive coupling; anda power supply, an electrode selector, and a compensator module having at least two high frequency output channels, each output channel being concurrently operable, separately controllable, and electrically coupled to at least one of the electrode pairs;wherein the power supply is configured to apply a voltage across each of the plurality of electrode pairs and to determine an area of tissue coverage of a partially covered electrode among the electrode pairs at the beginning of a cauterization cycle by measuring impedance across a circuit that includes the partially covered electrode, said circuit being driven by one of the high frequency output channels.
  • 30. A method of bipolar electrocautery, comprising the steps of: providing a plurality of adjacent first electrodes forming a first electrode array;providing one or more second electrodes;providing a plurality of opposed bipolar electrode pairs, each of the bipolar electrode pairs comprising one of the plurality of first electrodes and one of the one or more second electrodes; wherein each electrode of the electrode pairs comprises a surface coated with a dielectric or non-conductive material that allows RF energy to be transmitted between said electrodes via capacitive coupling; andproviding a power supply an electrode selector, and a compensator module having at least two high frequency output channels, each output channel being concurrently operable, separately controllable, and electrically coupled to at least one of the electrode pairs;selectively applying a voltage from the power supply across each of the plurality electrode pairs; anddetermining an area of partial tissue coverage of a partially covered electrode among the electrode pairs at the beginning of a cauterization cycle by measuring impedance across a circuit that includes the partially covered electrode, said circuit being driven by one of the high frequency, output channels.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation-in-part of U.S. application Ser. No. 11/382,635 filed May 10, 2006 now U.S. Pat. No. 7,862,565 and Ser. No. 11/371,988 filed Mar. 8, 2006 now U.S. Pat. No. 7,803,156, and claims the benefit thereof in accordance with 35 USC 120. U.S. application Ser. No. 11/382,635 filed May 10, 2006 in turn, claims the benefit of provisional applications 60/725,720 filed on Oct. 11, 2005 and 60/680,937 filed on May 12, 2005. The entireties of the foregoing applications are incorporated herein by reference.

US Referenced Citations (491)
Number Name Date Kind
3356408 Stutz Dec 1967 A
3527224 Rabinowitz Sep 1970 A
3709215 Richmond Jan 1973 A
3742955 Battista et al. Jul 1973 A
3845771 Vise Nov 1974 A
3920021 Hiltenbrandt Nov 1975 A
3970088 Morrison Jul 1976 A
4018230 Ochiai et al. Apr 1977 A
4041952 Morrison et al. Aug 1977 A
4072153 Swartz Feb 1978 A
4094320 Newton et al. Jun 1978 A
4200104 Harris Apr 1980 A
4231372 Newton Nov 1980 A
4492231 Auth Jan 1985 A
4532924 Auth et al. Aug 1985 A
4590934 Malis et al. May 1986 A
4671274 Sorochenko Jun 1987 A
4867649 Kawashima Sep 1989 A
4972846 Owens et al. Nov 1990 A
4976717 Boyle Dec 1990 A
4979948 Geddes et al. Dec 1990 A
4998527 Meyers Mar 1991 A
5037379 Clayman et al. Aug 1991 A
5041101 Seder et al. Aug 1991 A
5059782 Fukuyama Oct 1991 A
5078736 Behl Jan 1992 A
5108408 Lally Apr 1992 A
5133713 Huang et al. Jul 1992 A
5151102 Kamiyama Sep 1992 A
5156613 Sawyer Oct 1992 A
5178618 Kanadarpa Jan 1993 A
5190541 Abele et al. Mar 1993 A
5207691 Nardella May 1993 A
5217030 Yoon Jun 1993 A
5234425 Fogarty et al. Aug 1993 A
5250074 Wilk et al. Oct 1993 A
5267998 Hagen Dec 1993 A
5269780 Roos Dec 1993 A
5269782 Sutter Dec 1993 A
5273524 Fox et al. Dec 1993 A
5277201 Stern Jan 1994 A
5281216 Klicek Jan 1994 A
5282799 Rydell Feb 1994 A
5290287 Boebel et al. Mar 1994 A
5295990 Levin Mar 1994 A
5300068 Rosar et al. Apr 1994 A
5300087 Knoepfler Apr 1994 A
5312023 Green et al. May 1994 A
5324289 Eggers Jun 1994 A
5330471 Eggers Jul 1994 A
5330502 Hassler et al. Jul 1994 A
5336229 Noda Aug 1994 A
5336237 Chin et al. Aug 1994 A
5341807 Nardella Aug 1994 A
5342381 Tidemand Aug 1994 A
5352223 McBrayer et al. Oct 1994 A
5352235 Koros et al. Oct 1994 A
5354336 Kelman et al. Oct 1994 A
5356408 Rydell Oct 1994 A
5374277 Hassler et al. Dec 1994 A
5377415 Gibson Jan 1995 A
5391166 Eggers Feb 1995 A
5395369 McBrayer et al. Mar 1995 A
5396900 Slater et al. Mar 1995 A
5397320 Essig et al. Mar 1995 A
5403312 Yates et al. Apr 1995 A
5417687 Nardella et al. May 1995 A
5423814 Zhu et al. Jun 1995 A
5431676 Dubrul et al. Jul 1995 A
5438302 Goble Aug 1995 A
5443463 Stern et al. Aug 1995 A
5443470 Stern et al. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5447513 Davison et al. Sep 1995 A
5449355 Rhum et al. Sep 1995 A
5456684 Schmidt et al. Oct 1995 A
5458598 Feinberg et al. Oct 1995 A
5462546 Rydell Oct 1995 A
5472442 Klicek Dec 1995 A
5480399 Hebborn Jan 1996 A
5482054 Slater et al. Jan 1996 A
5484435 Fleenor et al. Jan 1996 A
5484436 Eggers et al. Jan 1996 A
5496312 Klicek Mar 1996 A
5496317 Goble et al. Mar 1996 A
5514134 Rydell et al. May 1996 A
5520698 Koh May 1996 A
5531744 Nardella et al. Jul 1996 A
5540684 Hassler, Jr. Jul 1996 A
5540685 Parins et al. Jul 1996 A
5542945 Fritzsch Aug 1996 A
5549606 McBrayer et al. Aug 1996 A
5549637 Crainich Aug 1996 A
5556397 Long et al. Sep 1996 A
5558100 Cox Sep 1996 A
5558671 Yates Sep 1996 A
5562700 Huitema et al. Oct 1996 A
5562701 Huitema et al. Oct 1996 A
5562702 Huitema et al. Oct 1996 A
5562720 Stern et al. Oct 1996 A
5564615 Bishop et al. Oct 1996 A
5569243 Kortenbach Oct 1996 A
5571100 Goble et al. Nov 1996 A
5573535 Viklund Nov 1996 A
5578052 Koros et al. Nov 1996 A
5599350 Schulze et al. Feb 1997 A
5601224 Bishop et al. Feb 1997 A
5603700 Daneshvar Feb 1997 A
5603711 Parins et al. Feb 1997 A
5611803 Heaven Mar 1997 A
5624452 Yates Apr 1997 A
5637110 Pennybacker Jun 1997 A
5637111 Sutcu et al. Jun 1997 A
5653692 Masterson et al. Aug 1997 A
5658281 Heard Aug 1997 A
5662662 Bishop et al. Sep 1997 A
5662676 Koninckx Sep 1997 A
5665085 Nardella Sep 1997 A
5665100 Yoon Sep 1997 A
5667526 Levin Sep 1997 A
5669907 Platt et al. Sep 1997 A
5673840 Schulze et al. Oct 1997 A
5673841 Schulze et al. Oct 1997 A
5674184 Hassler, Jr. Oct 1997 A
5674220 Fox et al. Oct 1997 A
5675184 Matsubayashi et al. Oct 1997 A
5680982 Schulze et al. Oct 1997 A
5681282 Eggers et al. Oct 1997 A
5683385 Kortenbach Nov 1997 A
5683388 Slater Nov 1997 A
5688270 Yates et al. Nov 1997 A
5693051 Schulze et al. Dec 1997 A
5697949 Giurtino et al. Dec 1997 A
5700261 Brinkerhoff Dec 1997 A
5702390 Austin et al. Dec 1997 A
5704534 Huitema et al. Jan 1998 A
5707369 Vatekunas et al. Jan 1998 A
5709680 Yates et al. Jan 1998 A
5713896 Nadella et al. Feb 1998 A
5715832 Koblish et al. Feb 1998 A
5718703 Chin Feb 1998 A
5720719 Edwards et al. Feb 1998 A
5728143 Gough et al. Mar 1998 A
5733283 Malis et al. Mar 1998 A
5735289 Pfeffer et al. Apr 1998 A
5735848 Yates et al. Apr 1998 A
5735849 Baden et al. Apr 1998 A
5741285 McBrayer Apr 1998 A
5743906 Parins et al. Apr 1998 A
5746750 Prestel et al. May 1998 A
5749895 Sawyer et al. May 1998 A
5755717 Yates et al. May 1998 A
5769849 Eggers Jun 1998 A
5776130 Buysse et al. Jul 1998 A
5788662 Antanavich et al. Aug 1998 A
5797906 Rhum et al. Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5810811 Yates et al. Sep 1998 A
5817091 Nardella et al. Oct 1998 A
5817092 Behl Oct 1998 A
5823066 Huitema et al. Oct 1998 A
5833689 Long Nov 1998 A
5833690 Yates et al. Nov 1998 A
5836990 Li Nov 1998 A
5840077 Rowden et al. Nov 1998 A
5855576 LeVeen et al. Jan 1999 A
5860975 Goble et al. Jan 1999 A
5891142 Eggers et al. Apr 1999 A
5893835 Witt et al. Apr 1999 A
5893874 Bourque et al. Apr 1999 A
5931835 Mackey Aug 1999 A
5931836 Hatta et al. Aug 1999 A
5954720 Wilson et al. Sep 1999 A
5976128 Schilling et al. Nov 1999 A
5979453 Savage et al. Nov 1999 A
6003517 Sheffield et al. Dec 1999 A
6004319 Goble et al. Dec 1999 A
6030384 Nezhat Feb 2000 A
6039735 Greep Mar 2000 A
6050993 Tu et al. Apr 2000 A
6050995 Durgin Apr 2000 A
6056744 Edwards May 2000 A
6056746 Goble et al. May 2000 A
6059766 Greff May 2000 A
6059782 Novak et al. May 2000 A
6066139 Ryan et al. May 2000 A
6068626 Harrington et al. May 2000 A
6071281 Burnside et al. Jun 2000 A
6074386 Goble et al. Jun 2000 A
6086586 Hooven Jul 2000 A
6090106 Goble et al. Jul 2000 A
6093186 Goble Jul 2000 A
6096037 Mulier et al. Aug 2000 A
6099550 Yoon Aug 2000 A
6123701 Nezhat Sep 2000 A
H1904 Yates et al. Oct 2000 H
6142992 Cheng et al. Nov 2000 A
6152920 Thompson et al. Nov 2000 A
6152932 Ternstrom Nov 2000 A
6162220 Nezhat Dec 2000 A
6174309 Wrublewski et al. Jan 2001 B1
6179832 Jones et al. Jan 2001 B1
6203541 Kappel Mar 2001 B1
6203542 Ellsberry et al. Mar 2001 B1
6206877 Kese et al. Mar 2001 B1
6210406 Webster Apr 2001 B1
6212426 Swanson Apr 2001 B1
6217894 Sawhney et al. Apr 2001 B1
6228084 Kirwan, Jr. May 2001 B1
6234178 Goble et al. May 2001 B1
6241139 Milliman et al. Jun 2001 B1
6245069 Gminder Jun 2001 B1
6254601 Burbank et al. Jul 2001 B1
6258085 Eggleston Jul 2001 B1
6277114 Bullivant et al. Aug 2001 B1
6283963 Regula Sep 2001 B1
6287304 Eggers et al. Sep 2001 B1
6290715 Sharkey et al. Sep 2001 B1
6293942 Goble et al. Sep 2001 B1
6293946 Thorne Sep 2001 B1
6296636 Cheng et al. Oct 2001 B1
6306134 Goble et al. Oct 2001 B1
6312430 Wilson et al. Nov 2001 B1
6322494 Bullivant et al. Nov 2001 B1
6327505 Medhkour et al. Dec 2001 B1
6334861 Chandler et al. Jan 2002 B1
6350274 Li Feb 2002 B1
6361559 Hauser et al. Mar 2002 B1
6364879 Chen et al. Apr 2002 B1
6371956 Wilson et al. Apr 2002 B1
6391024 Sun et al. May 2002 B1
6391029 Hooven et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6398781 Goble et al. Jun 2002 B1
H2037 Yates et al. Jul 2002 H
6416509 Goble et al. Jul 2002 B1
6423057 He et al. Jul 2002 B1
6428550 Vargas et al. Aug 2002 B1
6436096 Hareyama Aug 2002 B1
6440130 Mulier et al. Aug 2002 B1
6443952 Mulier et al. Sep 2002 B1
6464702 Schulze et al. Oct 2002 B2
6485486 Trembly et al. Nov 2002 B1
6485489 Teirstein et al. Nov 2002 B2
6491690 Goble et al. Dec 2002 B1
6494881 Bales et al. Dec 2002 B1
6500176 Truckai et al. Dec 2002 B1
6514252 Nezhat et al. Feb 2003 B2
6517530 Kleven Feb 2003 B1
6520185 Bommannan et al. Feb 2003 B1
6533784 Truckai et al. Mar 2003 B2
6546933 Yoon Apr 2003 B1
6554829 Schulze et al. Apr 2003 B2
6564806 Fogarty et al. May 2003 B1
6565560 Goble et al. May 2003 B1
6565561 Goble et al. May 2003 B1
6584360 Francischelli Jun 2003 B2
6610060 Mulier et al. Aug 2003 B2
6610074 Santilli Aug 2003 B2
6613048 Mulier et al. Sep 2003 B2
6616654 Mollenauer Sep 2003 B2
6616659 de la Torre et al. Sep 2003 B1
6619529 Green et al. Sep 2003 B2
6623482 Pendekanti et al. Sep 2003 B2
6626901 Treat et al. Sep 2003 B1
6645198 Bommannan et al. Nov 2003 B1
6645201 Utley et al. Nov 2003 B1
6648839 Manna et al. Nov 2003 B2
6652518 Wellman Nov 2003 B2
6656177 Truckai et al. Dec 2003 B2
6666859 Fleenor et al. Dec 2003 B1
6673085 Berg Jan 2004 B1
6676660 Wampler et al. Jan 2004 B2
6682526 Jones et al. Jan 2004 B1
6682527 Strul Jan 2004 B2
6695840 Schulze Feb 2004 B2
6699245 Dinger et al. Mar 2004 B2
6719754 Underwood et al. Apr 2004 B2
6722371 Fogarty et al. Apr 2004 B1
6726682 Harrington et al. Apr 2004 B2
6736814 Manna et al. May 2004 B2
6743229 Buysse et al. Jun 2004 B2
6746488 Bales Jun 2004 B1
6752154 Fogarty et al. Jun 2004 B2
6752803 Goldman et al. Jun 2004 B2
6755827 Mulier et al. Jun 2004 B2
6770070 Balbierz Aug 2004 B1
6770072 Truckai et al. Aug 2004 B1
6773435 Schulze et al. Aug 2004 B2
6776780 Mulier et al. Aug 2004 B2
6808525 Latterell et al. Oct 2004 B2
6817974 Cooper et al. Nov 2004 B2
6821273 Mollenauer Nov 2004 B2
6837888 Ciarrocca et al. Jan 2005 B2
6840938 Morley et al. Jan 2005 B1
6843789 Goble Jan 2005 B2
6852108 Barry et al. Feb 2005 B2
6858028 Mulier et al. Feb 2005 B2
6889089 Behl et al. May 2005 B2
6893435 Goble May 2005 B2
6896672 Eggers et al. May 2005 B1
6896673 Hooven May 2005 B2
6902536 Manna et al. Jun 2005 B2
6905506 Burbank et al. Jun 2005 B2
6908463 Treat et al. Jun 2005 B2
6913579 Truckai et al. Jul 2005 B2
6918909 Ohyama et al. Jul 2005 B2
6923803 Goble Aug 2005 B2
6923806 Hooven et al. Aug 2005 B2
6926712 Phan Aug 2005 B2
6929642 Xiao et al. Aug 2005 B2
6936048 Hurst Aug 2005 B2
6939346 Kannenberg et al. Sep 2005 B2
6953461 McClurken et al. Oct 2005 B2
6981628 Wales Jan 2006 B2
7063699 Hess et al. Jun 2006 B2
7090637 Danitz et al. Aug 2006 B2
7090673 Dycus et al. Aug 2006 B2
7090685 Kortenbach et al. Aug 2006 B2
7094235 Francischelli Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101372 Dycus et al. Sep 2006 B2
7101373 Dycus et al. Sep 2006 B2
7118587 Dycus et al. Oct 2006 B2
7125409 Truckai et al. Oct 2006 B2
7137980 Buysse et al. Nov 2006 B2
7159750 Racenet et al. Jan 2007 B2
7166102 Fleenor et al. Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7179254 Pendekanti et al. Feb 2007 B2
7195627 Amoah et al. Mar 2007 B2
7220260 Fleming et al. May 2007 B2
7238195 Viola Jul 2007 B2
7250048 Francischelli et al. Jul 2007 B2
7255697 Dycus et al. Aug 2007 B2
7267677 Johnson et al. Sep 2007 B2
7270664 Johnson et al. Sep 2007 B2
7276068 Johnson et al. Oct 2007 B2
7278991 Morris et al. Oct 2007 B2
7291143 Swanson Nov 2007 B2
7329256 Johnson et al. Feb 2008 B2
7364577 Wham et al. Apr 2008 B2
7367972 Francischelli et al. May 2008 B2
7410483 Danitz et al. Aug 2008 B2
7494039 Racenet et al. Feb 2009 B2
7506790 Shelton, IV et al. Mar 2009 B2
7513898 Johnson et al. Apr 2009 B2
7540872 Schechter et al. Jun 2009 B2
7588566 Treat et al. Sep 2009 B2
7641651 Nezhat et al. Jan 2010 B2
7794461 Eder et al. Sep 2010 B2
7803156 Eder et al. Sep 2010 B2
7862565 Eder et al. Jan 2011 B2
20010029367 Fleenor et al. Oct 2001 A1
20020062123 McClurken et al. May 2002 A1
20020062136 Hillstead et al. May 2002 A1
20020107514 Hooven Aug 2002 A1
20020124853 Burbank et al. Sep 2002 A1
20020128643 Simpson et al. Sep 2002 A1
20020151882 Marko et al. Oct 2002 A1
20020177848 Truckai et al. Nov 2002 A1
20020183738 Chee et al. Dec 2002 A1
20030018331 Dycus et al. Jan 2003 A1
20030078577 Truckai et al. Apr 2003 A1
20030144652 Baker et al. Jul 2003 A1
20030144653 Francischelli et al. Jul 2003 A1
20030153908 Goble Aug 2003 A1
20030158547 Phan Aug 2003 A1
20030171745 Francischelli et al. Sep 2003 A1
20030199869 Johnson et al. Oct 2003 A1
20030216726 Eggers et al. Nov 2003 A1
20030229344 Dycus et al. Dec 2003 A1
20030236549 Bonadio et al. Dec 2003 A1
20040006339 Underwood et al. Jan 2004 A1
20040010245 Cerier et al. Jan 2004 A1
20040049185 Latterell et al. Mar 2004 A1
20040068274 Hooven Apr 2004 A1
20040097919 Wellman et al. May 2004 A1
20040106917 Ormsby et al. Jun 2004 A1
20040122423 Dycus et al. Jun 2004 A1
20040143263 Schechter et al. Jul 2004 A1
20040199226 Shadduck Oct 2004 A1
20040236320 Protensko et al. Nov 2004 A1
20040236326 Schulze et al. Nov 2004 A1
20050015085 McClurken et al. Jan 2005 A1
20050021024 Hooven Jan 2005 A1
20050021026 Baily Jan 2005 A1
20050021027 Shields et al. Jan 2005 A1
20050033276 Adachi Feb 2005 A1
20050033277 Clague et al. Feb 2005 A1
20050033278 McClurken et al. Feb 2005 A1
20050033282 Hooven Feb 2005 A1
20050070895 Ryan et al. Mar 2005 A1
20050070978 Bek et al. Mar 2005 A1
20050090819 Goble Apr 2005 A1
20050096645 Wellman et al. May 2005 A1
20050096694 Lee May 2005 A1
20050107781 Ostrovsky et al. May 2005 A1
20050107784 Moses et al. May 2005 A1
20050113817 Isaacson et al. May 2005 A1
20050113820 Goble et al. May 2005 A1
20050113826 Johnson et al. May 2005 A1
20050119654 Swanson et al. Jun 2005 A1
20050131390 Heinrich et al. Jun 2005 A1
20050137591 Barry et al. Jun 2005 A1
20050149073 Arani et al. Jul 2005 A1
20050171530 Hooven Aug 2005 A1
20050171533 Latterell et al. Aug 2005 A1
20050187561 Lee-Sepsick et al. Aug 2005 A1
20050192568 Truckai et al. Sep 2005 A1
20050192633 Montpetit Sep 2005 A1
20050196421 Hunter et al. Sep 2005 A1
20050203500 Saadat et al. Sep 2005 A1
20050203504 Wham et al. Sep 2005 A1
20050209664 Hunter et al. Sep 2005 A1
20050226682 Chersky et al. Oct 2005 A1
20050256522 Francischelli et al. Nov 2005 A1
20050256524 Long et al. Nov 2005 A1
20050261676 Hall et al. Nov 2005 A1
20060025765 Landman et al. Feb 2006 A1
20060025812 Shelton Feb 2006 A1
20060041254 Francischelli et al. Feb 2006 A1
20060052778 Chapman et al. Mar 2006 A1
20060052779 Hammill Mar 2006 A1
20060064084 Haemmerich et al. Mar 2006 A1
20060064085 Schechter et al. Mar 2006 A1
20060079872 Eggleston Apr 2006 A1
20060142751 Treat et al. Jun 2006 A1
20060167451 Cropper Jul 2006 A1
20060189980 Johnson et al. Aug 2006 A1
20060190029 Wales Aug 2006 A1
20060199999 Ikeda et al. Sep 2006 A1
20060217709 Couture et al. Sep 2006 A1
20060226196 Hueil et al. Oct 2006 A1
20060229665 Wales et al. Oct 2006 A1
20060253117 Hovda et al. Nov 2006 A1
20060258954 Timberlake et al. Nov 2006 A1
20060259034 Eder et al. Nov 2006 A1
20060259035 Nezhat Nov 2006 A1
20060271037 Maroney et al. Nov 2006 A1
20060271038 Johnson et al. Nov 2006 A1
20060271041 Eder Nov 2006 A1
20060271042 Latterell et al. Nov 2006 A1
20060287674 Ginn et al. Dec 2006 A1
20060289602 Wales et al. Dec 2006 A1
20060293655 Sartor Dec 2006 A1
20070005053 Dando Jan 2007 A1
20070005061 Eder et al. Jan 2007 A1
20070055231 Dycus et al. Mar 2007 A1
20070062017 Dycus et al. Mar 2007 A1
20070073340 Shelton et al. Mar 2007 A1
20070128174 Kleinsek et al. Jun 2007 A1
20070129726 Eder et al. Jun 2007 A1
20070173804 Wham et al. Jul 2007 A1
20070173805 Weinberg et al. Jul 2007 A1
20070173811 Couture et al. Jul 2007 A1
20070179497 Eggers et al. Aug 2007 A1
20070185482 Eder Aug 2007 A1
20070208330 Treat et al. Sep 2007 A1
20070244538 Eder et al. Oct 2007 A1
20070250113 Hegeman et al. Oct 2007 A1
20070260242 Dycus et al. Nov 2007 A1
20070265613 Edelstein et al. Nov 2007 A1
20070282318 Spooner et al. Dec 2007 A1
20070282320 Buysse et al. Dec 2007 A1
20070299439 Latterell et al. Dec 2007 A1
20080039835 Johnson et al. Feb 2008 A1
20080045947 Johnson et al. Feb 2008 A1
20080114356 Johnson et al. May 2008 A1
20080172052 Eder et al. Jul 2008 A1
20080188844 McGreevy et al. Aug 2008 A1
20080195093 Couture et al. Aug 2008 A1
20080221565 Eder et al. Sep 2008 A1
20080228179 Eder et al. Sep 2008 A1
20080275446 Messerly Nov 2008 A1
20090018535 Schechter et al. Jan 2009 A1
20090138006 Bales et al. May 2009 A1
20090149853 Shields et al. Jun 2009 A1
20090157071 Wham et al. Jun 2009 A1
20090157072 Wham et al. Jun 2009 A1
20090157075 Wham et al. Jun 2009 A1
20090171354 Deville et al. Jul 2009 A1
20090182323 Eder et al. Jul 2009 A1
20090198272 Kerver et al. Aug 2009 A1
20090234347 Treat et al. Sep 2009 A1
20090240245 Deville et al. Sep 2009 A1
20090299367 Ginnebaugh et al. Dec 2009 A1
20100042093 Wham et al. Feb 2010 A9
20100280508 Eder Nov 2010 A1
20100298823 Cao et al. Nov 2010 A1
20110202058 Eder Aug 2011 A1
Foreign Referenced Citations (136)
Number Date Country
2061215 Feb 1992 CA
1250360 Apr 2000 CN
1882289 Dec 2006 CN
487269 May 1991 EP
440385 Jul 1991 EP
502268 Sep 1992 EP
562195 Sep 1993 EP
658333 Jun 1995 EP
536998 Apr 1996 EP
518230 May 1996 EP
0737446 Oct 1996 EP
875209 Apr 1998 EP
878169 Nov 1998 EP
640315 Dec 1998 EP
923907 Jun 1999 EP
640317 Sep 1999 EP
771176 Jul 2000 EP
1050278 Nov 2000 EP
1064886 Jan 2001 EP
833593 Feb 2001 EP
1254637 Nov 2002 EP
0717960 Feb 2003 EP
1293169 Mar 2003 EP
1293170 Mar 2003 EP
869742 May 2003 EP
1330989 Jul 2003 EP
1330991 Jul 2003 EP
1344498 Sep 2003 EP
873089 Oct 2003 EP
742696 Nov 2003 EP
1041933 Mar 2004 EP
959784 Apr 2004 EP
0794735 Jul 2004 EP
1004277 Jul 2004 EP
959786 Sep 2004 EP
913126 Oct 2004 EP
956827 Oct 2004 EP
1472984 Nov 2004 EP
1025807 Dec 2004 EP
1486177 Dec 2004 EP
1518498 Mar 2005 EP
1518499 Mar 2005 EP
927543 Apr 2005 EP
1532933 May 2005 EP
1586281 Oct 2005 EP
1621146 Feb 2006 EP
1632192 Mar 2006 EP
1637086 Mar 2006 EP
1 645 234 Apr 2006 EP
1645237 Apr 2006 EP
1747761 Jan 2007 EP
1767164 Mar 2007 EP
1852081 Nov 2007 EP
1862138 Dec 2007 EP
1039862 May 2008 EP
1707143 Jun 2008 EP
1958583 Aug 2008 EP
2065006 Jun 2009 EP
2106764 Oct 2009 EP
2110093 Oct 2009 EP
09-501328 Feb 1997 JP
11 70123 Mar 1999 JP
11 70124 Mar 1999 JP
A 11070123 Mar 1999 JP
A 11070124 Mar 1999 JP
2001-518344 Oct 2001 JP
A 2003088534 Mar 2003 JP
A 2004049566 Feb 2004 JP
A 2005021703 Jan 2005 JP
2005-512671 May 2005 JP
A 2005144193 Jun 2005 JP
WO 9222257 Dec 1992 WO
WO 9308754 May 1993 WO
WO 9400060 Jan 1994 WO
WO9426179 Nov 1994 WO
WO 9426228 Nov 1994 WO
WO 9502371 Jan 1995 WO
WO 9514436 Jun 1995 WO
WO 9525471 Sep 1995 WO
WO 9605776 Feb 1996 WO
WO9616605 Jun 1996 WO
WO-9619152 Jun 1996 WO
WO 9623449 Aug 1996 WO
WO 9724073 Jul 1997 WO
WO 9724074 Jul 1997 WO
WO 9724995 Jul 1997 WO
WO 9812999 Apr 1998 WO
WO 9843548 Oct 1998 WO
WO 9853750 Dec 1998 WO
WO 9917670 Apr 1999 WO
WO9917670 Apr 1999 WO
WO 9923933 May 1999 WO
WO 9951155 Oct 1999 WO
WO 9951158 Oct 1999 WO
WO 9952459 Oct 1999 WO
WO 9956646 Nov 1999 WO
WO 0013192 Mar 2000 WO
WO 0013193 Mar 2000 WO
WO 0047124 Aug 2000 WO
WO-0051512 Sep 2000 WO
WO0112090 Feb 2001 WO
WO 0135846 May 2001 WO
WO 0154602 Aug 2001 WO
WO 0158372 Aug 2001 WO
WO0158373 Aug 2001 WO
WO 0182812 Nov 2001 WO
WO 0224092 Mar 2002 WO
WO 0236028 May 2002 WO
WO 02067798 Jul 2002 WO
WO 02058542 Aug 2002 WO
WO 02071926 Sep 2002 WO
WO 03024348 Mar 2003 WO
WO 03053266 Jul 2003 WO
WO03053266 Jul 2003 WO
WO03088806 Oct 2003 WO
WO 03096886 Nov 2003 WO
WO 03103522 Dec 2003 WO
WO2004032776 Apr 2004 WO
WO2004032596 Apr 2004 WO
WO2004073490 Sep 2004 WO
WO 2004098383 Nov 2004 WO
WO 2004103156 Dec 2004 WO
20050010212 Feb 2005 WO
WO 2005009213 Feb 2005 WO
WO 2005034729 Apr 2005 WO
WO 2005079901 Sep 2005 WO
WO 2005115251 Dec 2005 WO
WO2006060431 Jun 2006 WO
WO 2006124601 Nov 2006 WO
WO2006124518 Nov 2006 WO
WO2007002227 Jan 2007 WO
WO2007082061 Jul 2007 WO
WO2008094554 Aug 2008 WO
WO2008094564 Aug 2008 WO
WO2009070780 Jun 2009 WO
WO2009154976 Dec 2009 WO
Non-Patent Literature Citations (111)
Entry
Aoki, T. et al.; Thoracoscopic Resection of the Lung With the Ultrasonic Scalpel; Ann Thorac Surg. Apr. 1999; 67 (4): 1181-3; Department of Thoracic Surgery, Saiseikai Kanagawaken Hospital, Yokohama, Japan.
Arthrocare Receives Clearance to Market Coblation-Based Devices for Gynecology and Laparoscopic Surgery; Clearance Includes Plasma Forceps and 21 Specific Indications; Business Wire, p0524; Oct. 25, 2001.
Bergamaschi, R. et al; Laparoscopic Intracorporeal Bowel Resection With Ultrasound Versus Electrosurgical Dissection; JSLS. Jan.-Mar. 2001; 5 (1): 17-20; National Center for Advanced Laparoscopic Surgery, Tondheim, Norway. r.bergamaschi@altavista.net.
Berguer, Ramon et al.; Sages 2001 Hands-On Course I—Taking It to the Next Level: Advanced Laparoscopic Techniques; http://www.sages.org/01program/syllabi/ho1/ho1.html#schirme.
Briani, S. et al.; Pseudo-Bipolar Electrocoagulation With a Branched Forceps; Minerva E Neurochir. 1967; 11 (3): 306-11.
Cakan, A. et al.; The Histological Effect of Harmonic Scalpel and Electrocautery in Lung Resections. An Experimental Study in a Rat Model; J Cardiovasc Surg (Torino). Feb. 2004; 45 (1): 63-5; Department of Thoracic Surgery, Ege University School of Medicine, Izmir, Turkey. alpcakan@gohip.com.
Ceviker, N. et al.; A New Coated Bipolar Coagulator: Technical Note; Acta Neurochir (Wien). 1998; 140 (6): 619-20; Department of Neurosurgery, Faculty of Medicine, Gazi University, Ankara, Turkey.
Cherchi, PL, et al.; Utility of Bipolar Electrocautery Scissors for Cervical Conization; Eur J Gynaecol Oncol. 2002; 23 (2): 154-6; Department of Pharmacology, Gynecology and Obstetrics, University of Sassari, Italy.
Circon Corporation—Company Report; Investext, p. 1-13; Jan. 3, 1995.
Colvin, D.P. et al.; Development of an Endoscopic RF Hyperthermia System for Deep Tumor Therapy; American Society of Mechanical Engineers, Heat Transfer Division, (Publication) HTD v. 95. Publ by ASME (BED-v 7), New York, NY, USA p. 25-30; 1987.
Corson, S.L.; Two New Laparoscopic Instruments: Bipolar Sterilizing Forceps and Uterine Manipulator; Medical Instrumentation vol. 11, No. 1 p. 7-8; Jan.-Feb. 1977; USA.
Curon Medical Announces Presentation of Positive Clinical Study Results of Stretta(R) Procedure for Gastroesophageal Reflux Disease (GERD); PR Newswire, pNYW07920032002; Mar. 20, 2002.
Curon Announces The Publication of Data Supporting Durability and Effectiveness of Stretta (R) System;—Positive One Year Follow-Up Data of U.S. Clinical Trial Published in Gastrointestinal Endoscopy; PR Newswire, pNYTH10307022002; Feb. 7, 2002.
Daniel, P. et al.; Ultrasonic Sealing of the Lunq Parenchyma After Atypical Resection; Z Exp Chir Transplant Kunstliche Organe. 1987; 20 (2): 117-21.
Digeronimo, EM et al.; Cut-Blot-Coagulate: A New Time Saving Device; Plast Reconstr Surg. Nov. 1982; 70 (5): 639-40.
Dubuc-Lissoir, J.; Use of a New Energy-Based Vessel Ligation Device During Laparoscopic Gynecologic Oncologic Surgery; Surg Endosc. Mar. 2003; 17 (3): 466-8. Epub Oct. 31, 2002; Department of Obstetrics and Gynecology, CHUM—Notre-Dame Hospital, Pavillon Charles-Simard, 2065 Alexandre-de-Seve, 4th Floor, Montreal, Quebec, Canada, H2L 2W5. josee.dubuc-lissoirchum@ssss.gouv.qc.ca.
Eichfeld U., et al.; Evaluation of Ultracision in Lung Metastatic Surgery; Ann Thorac Surg. Oct. 2000; 70 (4): 1181-4; Department of Surgery I, General Surgery, Surgical Oncology and Thoracic Surgery, and Institute of Pathology, University of Leipzig, Germany. eichu@medizin.uni-leipzig.de.
Enable Medical Introduces Second Generation Bipolar Scissors; Health Industry Today, pNA; Dec. 1998.
Ercoli, A. et al.; Radiofrequency Bipolar Coagulation for Radical Hysterectomy Technique, Feasibility and Complications; Int J Gynecol Cancer. Mar.-Apr. 2003; 13 (2): 187-91;Department of Obstetrics and Gynecology, Catholic University, Rome, Italy.
Everest Medical Announces Introduction of 3mm Bipolar Forceps; PR Newswire, p1002MNW021; Oct. 2, 1996.
Everest Medical Discusses Patent Status; Forecasts $1 Million Revenue First Quarter; Introduces Next Generation Bipolar Scissors; PR Newswire, pN/A; Mar. 31, 1994.
Everest Medical Introduces New Quadripolar (TM) Cutting Forceps at the Global Congress of Gynecologic Endoscopy Meeting; PR Newswire p8927; Nov. 8, 1999.
Everest Medical Releases Bicoag (TM) for Use in Treating Bleeding Ulcers; News Release, p. 1; May 9, 1990.
Everest Medical Reports Record First Quarter Results; Introduces Next Generation Bipolar Scissor; PR Newswire, pN/A; Apr. 19, 1994.
Forestier D. et al.; Do Bipolar Scissors Increase Postoperative Adhesions? An Experimental Double-Blind Randomized Trial; Ann Chir. Nov. 2002; 127 (9): 680-4; Service de chirurgie generale et digestive, Hotel-Dieu, boulevard Leon-Malfreyt, 63058 Clermont-Ferrand, France.
Gerasin VA et al.; Endoscopic Electrosurgery of the Trachea and Bronchi; Grudn Khir. Sep.-Oct. 1988; (5): 50-3.
Gyr, T. et al.; Minimal Invasive Laparoscopic Hysterectomy With Ultrasonic Scalpel; Am J Surg. Jun. 2001; 181 (6): 516-9; Department of Obstetrics and Gynecology, Regional Hospital, Lugano, Switzerland.
Gyrus Medical: Cutting Forceps; http://www.gyrusgroup.com/medical/products—item.asp?id=7.
Gyrus Medical: Lyons TM Dissecting Forceps; http://www.gyrusgroup.com/medical/products—item.asp?id=8.
Gyrus Medical: LP Scissors; http://www.gyrusgroup.com/medical/products—item.asp?id=11.
Gyrus Medical: Micro/Macro-Jaw Forceps; http://www.gyrusgroup.com/medical/products—item.asp?id=13.
Gyrus Medical: Seal TM Open Forceps; http://www.gyrusgroup.com/medical/products—item.asp?id=15.
Harrell, AG et al.; Energy Sources in Laparoscopy; Semin Laparosc Surg. Sep. 2004; 11 (3): 201-9; Carolinas Laparoscopic and Advanced Surgery Program, Carolinas Medical Center, Charlotte, NC 28203, USA.
Hayashi A. et al.; Experimental and Clinical Evaluation of the Harmonic Scalpel in Thoracic Surgery; Kurume Med J. 1999; 46 (1): 25-9; Department of Surgery, Kurume University School of Medicine, Japan.
Hefni, MA et al.; Safety and Efficacy of Using the Ligasure Vessel Sealing System for Securing the Pedicles in Vaginal Hysterectomy: Randomised Controlled Trial; BJOG. Mar. 2005; 112 (3): 329-33; Department of Gynecology, Benenden Hospital, Kent TN17 7AX, UK.
Heniford BT et al.; Initial Results With an Electrothermal Bipolar Vessel Sealer; Surg Endosc. Aug. 2001; 15 (8): 799-801. Epub May 14, 2001; Carolinas Laparoscopic and Advanced Surgery Program, Department of General Surgery, Carolinas Medical Center, 1000 Blythe Boulevard, MEB # 601, Charlotte, NC, USA.
Kamat, AA et al.; Superiority of Electrocautery Over the Suture Method for Achieving Cervical Cone Bed Hemostasis; Obstet Gynecol. Oct. 2003; 102 (4): 726-30; Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030, USA. akamat@bcm.tmc.edu.
Kato, K. et al.; A Computer Based. Temperature Controlled Bipolar Electrocoagulation System; Eur J Obstet Gynecol Reprod Biol. Sep. 1996; 68 (1-2): 119-22; Department of Obstetrics and Gynecology, University of Essen, Germany.
Kennedy, JS et al.; High-Burst-Strength, Feedback-Controlled Bipolar Vessel Sealing; Surg Endosc. Jun. 1998; 12 (6): 876-8; Valleylab, Inc., 5920 Longbow Drive, Boulder, CO 80301, USA.
Kim, Byungkyu et al.; Design and Fabrication of a Locomotive Mechanism for Capsule-Type Endoscopes Using Shape Memory Alloys (Smas); IEEE/ASME Transactions on Mechatronics, vol. 10, No. 1, p. 77-86; Feb. 2005; USA.
Koch, C. et al.; Determination of Temperature Elevation in Tissue During the Application of the Harmonic Scalpel; Ultrasound Med Biol. Feb. 2003; 29 (2): 301-9; Ultrasonics Section, Physikalisch-Technische Bundesanstalt Braunschweig, B raunschweig, Germany. christian.koch@ptb.de.
Kohler C. et al.; Laparoscopic Coagulation of the Uterine Blood Supply in Laparoscopic-Assisted Vaginal Hysterectomy is Associated with Less Blood Loss; Eur J Gynaecol Oncol. 2004; 25 (4): 453-6; Department of Gynecology, Friedrich Schiller University, Jena, Germany.
Kung, RC et al; A New Bipolar System for Performing Operative Hysetroscopy in Normal Saline; Aug. 1999; 6 (3): 331-6J Am Assoc Gynecol Laparosc. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list—uids=10459037&query—hl=1.
Kwok, A. et al.; Comparison of Tissue Injury Between Laparosonic Coagulating Shears and Electrosurgical Scissors in the Sheep Model; J Am Assoc Gynecol Laparosc. Aug. 2001; 8 (3): 378-84; Department of Endosurgery, Women's Institute, University of Sydney, Australia.
Landman J. et al.; Evaluation of a Vessel Sealing System, Bipolar Electrosurgery, Harmonic Scalpel, Titanium Clips, Endoscopic Gastrointestinal Anastomosis Vascular Staples and Sutures for Arter lal and Venous Ligation in a Porcine Model; J Urol. Feb. 2003; 169 (2): 697-700; Department of Surgery (Division of Urology), Washington University School of Medicine, St. Louis, Missouri, USA.
Lantis, JC II et al.; Comparison of Coagulation Modalities in Surgery; J Laparoendosc Adv Surg Tech A. Dec. 1998; 8 (6): 381-94; Surgical Research Laboratory, New England Medical Center, Boston, Massachusetts, USA.
Laparoscopic Lasers Vs. Electrosurgery: Debated Technology Choices; The BBI Newsletter, v.14, n. 6, pN/A; Jun. 6, 1991.
Levy, Barbara et al.; Update on Hysterectomy: New Technology AndTechniques;http://www.obgmanagement.com/supplements/pdf/hysterectomy.pdf; A supplement to OBG Management, Feb. 2003.
Levy, Barbara; Use of a New Vessel Lilgation Device During Vaginal Hysterectomy; As presented at FIGO 2000, Washington, D.C.; University of Washington School of Medicine; Federal Way, Washington, USA; © 2000 Valleylab.
Lin, J. et al.; Application of Ultrasonic Scalpel in Gynecologic Operative Laparoscopy; Chin Med J (Engl.) Dec. 2001; 114 (12): 1283-5; Department of Gynecology, Women's Hospital, Medical School of Zhejiang University, Hangzhou 310006, China. Zuying@mail.hz.zj.cn.
Lyons, TL et al.; An Innovative Bipolar Instrument for Laparoscopic Surgery; JSLS. Jan.-Mar. 2005; 9 (1): 39-41; Center for Women's Care & Reproductive Surgery, Atlanta, Georgia, USA cwcrs@mindspring.com.
Market and Technology Updates: Bipolar Endoscopic Device; The BBI Newsletter, v.13, n. 1, pN/A; Jan. 24, 1990.
Matsumura Y. et al.; New Surgical Technique of Pulmonary Segmentectomy by Ultrasonic Scalpel and Absorbable Sealing Materials; Kyobu Geka. Jan. 2004; 57 (1): 31-7; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Mundt, C. et al.; Advanced Sensor Systems for Improved Labor and Fetal Monitoring; ISA TECH/EXPO Technology Update Conference Proceedings v. 2 n. 2 1998, p. 79-89; 1998.
Nikolov, N. et al.; Remote Controllable Vessel Occlusion Device; Med Biol Eng Comput. Jan. 1978; 16 (1): 116-7.
U.S. Patent Issued for Novare Surgical Systems Cygnet (R) Surgical Clamp; Novare Signs Multi-Year Supply Agreement With Boston Scientific; PR Newswire, pNA; Sep. 2, 2003.
OU, CS et al.; Total Laparoscopic Hysterectomy Using Multifunction Grasping, Coagulating, and Cutting Forceps; J Laparoendosc Adv Surg Tech A. Apr. 2004; 14 (2): 67-71; Department of Research and Development, Northwest Hospital and University of Washington School of Medicine, Seattle, Washington 98155, USA. cou@nwhsea.org.
Pavlov, IUV et al.; Ultrasonic Technologies in Diagnosis and Treatment of Patients With Surgical Diseases of Lungs and Pleura; Khirurgiia (Mosk). 2003; (8): 30-4.
Petrakis, IE et al.; Use of the Ligasure Vessel Sealer in Total Abdominal Hysterectomy; Int J Gynaecol Obstet. Jun. 2005; 89 (3): 303-4. Epub Mar. 2, 2005.; Department of General Surgery, University General Hospital of Heraklion, University of Crete, Heraklion, Crete, Greece. petrakis@post.com.
Quadripolar Cutting Forceps Introduced by Everest Medical; Health Industry Today, v. 63, n. 1, pNA; Jan. 2000.
Radiofrequency Energy Proven Effective Against Leading Cause of Obstructive Sleep Apnea; Business Wire, p09140175; Sep. 14, 1998.
Raestrup, H. et al.; Dissection Technique—Is Ultrasound the Best Method?; Kongressbd Dtsch Ges Chir Kongr. 2001; 118: 69-70; Universitatsklinik Fur Allgemeine Chirurgie, Hoppe-Seyler-Strasse 3, 72076 Tubingen.
Robinson JL et al.; Bipolar Diathermy; Can J Surg. Sep. 1974; 17 (5): 287-91.
Srisombut, C. et al.; Laparoscopic Hysterectomy Using Laparosonic Coagulating Shears: Experience of 15 Cases; J Med Assoc Thai. Aug. 2000; 83 (8): 915-20; Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Stanojevic, D. et al.; An Ultrasonic Scalpel for Laparoscopic Gynecologic Surgery; Srp Arh Celok Lek. May-Jun. 1998; 126 (5-6): 214-6; Narodni Front Department of Gynecology and Obstetrics, Dr. Dragisha Mishovitsh Medical Centre, Belgrade.
Sugi, K. et al.; Use of the Bipolar Vessel Sealing System in Lung Resection; Kyobu Geka. Jul. 2003; 56 (7): 551-4; Department of Clinical Research, National Sanyo Hospital, Ube, Japan.
Tajiri M. et al.; Evaluation of an Ultrasonic Cutting and Coagulating System (Harmonic Scalpel) for Performing a Segmental and Wedge Resection of the Lung ; Kyobu Geka. Dec. 1998; 51 (13): 1116-9; Department of Surgery, Kan to Rosai Hospital, Kawasaki, Japan.
Tamussino, K. et al.; Electrosurgical Bipolar Vessel Sealing for Radical Abdominal Hysterectomy; Gynecol Oncol. Feb. 2005; 96 (2): 320-2;Department of Obstetrics and Gynecology, Medical University of Graz, Auenbruggerplatz 14, A-8036 Graz, Austria. Karl.tamussino@meduni-graz.at.
The Gynecare Versapoint; http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentId=edea000100001747&parentId=fc0de00100000; All contents copyright @ Johnson & Johnson Gateway, LLC 2000-2005.
Timor-Tritsch IE et al.; Transvaginal Ultrasound-Assisted Gynecologic Surgery: Evaluation of a New Device to Improve Safety of Intrauterine Surgery; Am J Obstet Gynecol. Oct. 2003; 189 (4): 1074-9; Department of Obstetrics and Gynecology, New York University School of Medicine, NY 10016, USA. ilan.timor@med.nyu.edu.
Tucker, RD et al.; Bipolar Electrosurgical Sphincterotomy; Gastrointest Endosc. Mar.-Apr. 1992; 38 (2): 113-7; Department of Pathology, University of Iowa Hospitals Clinics, Iowa City 52242.
Tucker, R.D. et al.; Capacitive Coupled Stray Currents During Laparoscopic and Endoscopic Electrosurgical Procedures; Biomedical Instrumentation & Technology vol. 26, No. 4 p. 303-11; Jul.-Aug. 1992; USA.
Valley Forge Scientific Corp.—Company Report; Investext, p. 1-1; Jan. 27, 1993.
Valleylab Products—Electrosurgical Forceps: The Surgeon's Choice for Quality and Precision; http://www.valleylab.com/product/es/accessories/forceps—over.html; © 2005 valleylab.
Valleylab Products—Ligasure TM Vessel Sealing System; http://www.valleylab.com/product/vessel—seal/index.html.
Weyl, BP; How to Increase the Proportion of Vaginal Hysterectomies-Bipolar Coagulation; Am J Obstet Gynecol. Sep. 1999; 181 (3): 768.
Wilson, Fred; Cool Tool, Hot New Application: Radiofrequency Energy Removes Heads, Neck Tumors. (Dermatologic Surgery): Dermatology Times, v. 24, n. 8, p. 54; Aug. 2003.
Zhi, Xu-Ting et al.; Management of Gastroesophageal Reflux Disease: Medications, Surgery, Or Endoscopic Therapy?(Current Status and Trends); Journal of Long-Term Effects of Medical Implants v. 15 n. 4 2005. p. 375-388; 2005.
Abu-Rustum, NR, et al.; Transperitoneal Laparoscopic Pelvic and Para-Aortic Lymph Node Dissection Using The Argon-Beam Coagulator and Monopolar Instruments: An 8-Year Study and Description of Technique; Gynecol Oncol. Jun. 2003.; 89 (3): 50413; Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. gynbreast@mskcc.org.
ERBE Elektromedizin GmbH; ERBE BiClamp Brochure; http://www.erbe-med.com/erbe/media/Marketingmaterialien/85100-139—ERBE—EN—BiClamp—D024676.pdf; downloaded Jan. 24, 2011; 6 pgs.
Gyrus ACMI (an Olympus Company); PKS Seal (product page); http://www.gyrusacmi.com/user/display.cfm?display=product&pid=9024; downloaded Jan. 24, 2011; 1 page.
Kovac; Transvaginal hysterectomy: rationale and surgical approach; Obstet. Gynecol.; vol. 103; pp. 1321-1325; 2004.
Live Tissue Connect Technologies; company profile; (http://www.onemedplace.com/database/compdisplay—print.php?CompanyID=11508); 1 pg.; Oct. 19, 2010 (downloaded Feb. 7, 2011).
McClurken et al.; Collagen shrinkage and vessel sealing; Technical brief #300. Dover, NH: Tissue Link Medical; 2001.
Nojarov et al.; High-energy scissors mode; Phys Rev C Nucl Phys; vol. 51; No. 5; pp. 2449-2456; 1995 (http://arxiv.org/abs/nucl-th/9502001v1).
Parikh et al.; Three dimensional virtual reality model of the normal female pelvic floor; Annals of Birnedical Engineering; vol. 32; pp. 292-296; Feb. 2004.
Sages 2001 Nurses Program, Session 1; http://sages.org/01program/syllabi/nurse/nurse.html; downloaded Jan. 24, 2011; 5 pgs.
Surgrx 510(K) Summary (# K031133); Palo Alto, CA; 5 pgs.; Jul. 3, 2003.
Treat; A new thermal device for sealing and dividing blood vessels; http://www.starioninstruments.com/PDFs/Treat.pdf; downloaded Jun. 29, 2005; 2 pgs.
Tyco Healthcare; The LigaSure Vessel Sealing System (Brochure); Apr. 2002; 8 pgs.
Nezhat et al.; U.S. Appl. No. 08/948,282 entitled “Method and systems for organ resection,” filed Oct. 9, 1997.
Eder, Joseph C.; U.S. Appl. 12/200,798 entitled “Assisted systems and methods for performing transvaginal hysterectomies,” filed Aug. 28, 2008.
Koss et al.; U.S. Appl. No. 12/748,229 entitled “Impedance mediated power delivery for electrosurgery,” filed Mar. 26, 2010.
Koss et al.; U.S. Appl. No. 12/907,646 entitled “Impedance mediated control of power delivery for electrosurgery,” filed Oct. 19, 2010.
Walberg, Erik; U.S. Appl. No. 13/021,633 entitled “Laparoscopic radiofrequency surgical device,” filed Feb. 4, 2011.
Chinese Application No. 200880005429.2, Second Office Action mailed Mar. 6, 2013 with English translation.
Canadian Application No. 2,677,300, Examination Report mailed Apr. 18, 2013.
European Application Serial No. 08826108.6, Extended European Search Report mailed Mar. 30, 2012, 7 pgs.
Examination Report for Canadian Application No. 2,677,300 Dated Mar. 28, 2012.
Final Office Action for U.S. Appl. No. 12/062,516 dated Jul. 27, 2012.
Examination Report for Canadian Application No. 2,677,444 dated Jul. 3, 2012.
Chinese Application Serial No. 200880005429.2, First Office Action mailed Aug. 20, 2012, 21 pgs.
U.S. Appl. No. 12/410,322, Non-Final Office Action mailed Oct. 17, 2012, 56 pgs.
Examination Report issued in Japanese Patent Application No. 2012 173318, dispatched on Aug. 26, 2013.
Chinese Application Serial No. 2008800056131, Third Office Action mailed Aug. 30, 2013.
Examination Report issued in corresponding Japanese Patent Application No. 2011 509759, dispatched on Aug. 6, 2013.
Chinese Application Serial No. 200880005613.7, Second Office Action mailed Jan. 31, 2013, 11 pgs. (English Translation).
Australian Examination Report for application No. 2008275543, dated Nov. 9, 2010.
Canadian Examination Report for application No. 2,677,444, dated Aug. 18, 2011.
Japanese Examination Report for application No. 2009-549183, dated Nov. 1, 2011 with English translation.
Canadian Application No. 2,723,016, Office Action mailed Nov. 12, 2013.
Related Publications (1)
Number Date Country
20070185482 A1 Aug 2007 US
Provisional Applications (2)
Number Date Country
60725720 Oct 2005 US
60680937 May 2005 US
Continuation in Parts (2)
Number Date Country
Parent 11382635 May 2006 US
Child 11671911 US
Parent 11371988 Mar 2006 US
Child 11382635 US